期刊
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
卷 14, 期 5, 页码 318-323出版社
W B SAUNDERS CO LTD
DOI: 10.1016/j.seizure.2005.04.002
关键词
epilepsy syndromes; hippocampal atrophy; cortical dysplasia; prognosis; localization-related epilepsy
A total of 558 patients with a range of locatization-related epilepsy syndromes starting treatment in a single centre were followed over a period of up to 20 years. Overall, 343 (62%) patients became seizure free for 12 months or more (responders), 92% of whom (57% of total population) remained in remission until the end of follow-up. Only 27 (5%) responders relapsed and subsequently developed refractory epilepsy. The remaining 215 (38%) patients never became seizure free for any 12-month period. There were no significant differences in outcome between cryptogenic (56% remission) and symptomatic (57% remission) epitepsies. Patients with underlying cortical atrophy (71% remission; p < 0.05) or cerebrovascular disease (70% remission; p < 0.01) did better, white those with traumatic brain injury (35% remission; p < 0.001) did worse than the remainder of the symptomatic group. Remission rates in patients with cortical dysplasias (60%), hippocampal atrophy (50%) and primary brain tumors (52%) appeared no different from those with other symptomatic epitepsies. Overall, 20-40% patients with each epilepsy syndrome reported no further seizures after starting AED treatment including 21% with hippocampal atrophy and 33% with cortical dysplasia. More than 50% of patients developing localization-related epilepsy during adolescence or in adulthood had a good outcome. Prognosis in those with underlying hippocampal. atrophy or cortical dysplasia was not always bad. (c) 2005 BEA Trading Ltd. Published by Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据